Literature DB >> 6121767

Benzodiazepine withdrawal phenomena.

C Hallstrom, M Lader.   

Abstract

A withdrawal syndrome is described in 10 patients who claimed to be unable to discontinue benzodiazepines. A high dose group took the equivalent of a mean of 135 mg diazepam/day, and the normal dose group of 20 mg/day. Associated with the gradual reduction of medication was the emergence of severe symptoms of anxiety as well as sensory intolerance, perceptual disturbances and weight loss. The withdrawal syndrome subsided after 2 weeks and was similar in both groups of patients. EEG changes were detected on withdrawal opposite to those known to be associated with initiation of diazepam treatment. The measures tended to revert to the baseline after a drug-free period. One reason why chronic users of diazepam experience difficulty in stopping medication may be the development of a withdrawal syndrome even after moderate dosage.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6121767     DOI: 10.1159/000468500

Source DB:  PubMed          Journal:  Int Pharmacopsychiatry        ISSN: 0020-8272


  11 in total

1.  Sex-related elevation in cortisol during chronic treatment with alprazolam associated with enhanced cognitive performance.

Authors:  Nunzio Pomara; Lisa M Willoughby; James C Ritchie; John J Sidtis; David J Greenblatt; Charles B Nemeroff
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

2.  Controlled study of withdrawal symptoms and rebound anxiety after six week course of diazepam for generalised anxiety.

Authors:  K G Power; D W Jerrom; R J Simpson; M Mitchell
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-27

3.  Benzodiazepine withdrawal: an unfinished story.

Authors:  H Ashton
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-14

4.  Treatment of benzodiazepine withdrawal symptoms with carbamazepine.

Authors:  D Garcia-Borreguero; T Bronisch; S Apelt; A Yassouridis; H M Emrich
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

Review 5.  Classics in chemical neuroscience: diazepam (valium).

Authors:  Nicholas E Calcaterra; James C Barrow
Journal:  ACS Chem Neurosci       Date:  2014-02-27       Impact factor: 4.418

6.  Behavioural approaches to anxiety disorders.

Authors:  L M Drummond
Journal:  Postgrad Med J       Date:  1993-03       Impact factor: 2.401

Review 7.  Withdrawing Benzodiazepines in Patients With Anxiety Disorders.

Authors:  Malcolm Lader; Andri Kyriacou
Journal:  Curr Psychiatry Rep       Date:  2016-01       Impact factor: 5.285

8.  The EEG in hypnosedative drug withdrawal and dependence.

Authors:  B van Sweden
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

9.  Reversal by alpha-2 agonists of diazepam withdrawal hyperactivity in rats.

Authors:  J Kunchandy; S K Kulkarni
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 10.  Guidelines for the rational use of benzodiazepines. When and what to use.

Authors:  H Ashton
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.